drugset / Trial / NCT04066478

Does DHEA IVF Outcomes in Poor Responders?

NCT04066478

Phase 2/3 Suspended 400 enrolled Homerton University Hospital NHS Foundation Trust
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a RCT to examine whether DHEA is capable of improving results for poor responders to ovarian stimulation during IVF treatment

Timeline

Start
2017-10-08
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydroepiandrosterone Other / unclassified 75 mg